Back to search

United States· US:51662-1483_2b39b839-0c7c-de03-e063-6294a90a243e

SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT

A medicinal product containing methylprednisolone sodium succinate, registered in United States by HF Acquisition Co LLC, DBA HealthFirst.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSOLU-MEDROL(R) METHYLPREDNISOLONE SOD…ATC—REGISTER NO.US:51662-1483_2b39b83…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHYLPREDNISOLONE SODIUM SUCCINATE
Manufacturer
HF Acquisition Co LLC, DBA HealthFirst
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    5166214831
    1 VIAL in 1 CARTON (51662-1483-1) / 4 mL in 1 VIAL
  • ndc11
    51662-1483-1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Methylprednisolone sodium succinate in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylprednisolone sodium succinate products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Solu-Medrol
  • Bulgaria · Метилпреднизолон Чайкафарма
  • Czechia · Solu-Medrol
  • Germany · Methylprednisolon Hikma, Metypred
  • Spain · Urbason
  • France · Methylprednisolone Hikma
  • United Kingdom (Northern Ireland) · Methylprednisolone Hikma Farmacêutica (Portugal), Methylprednisolone Pfizer
  • Hungary · Metilprednizolon Teva
  • Italy · Cortrium, Lisamethyle
  • Poland · Meprelon
  • Portugal · Metilprednisolona Hikma
  • Slovakia · Metylprednizolón Hikma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdedf076-1b14-48a4-96a7-99aa8a39dea4
GET /v1/drugs/cdedf076-1b14-48a4-96a7-99aa8a39dea4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR; INTRAVENOUS",
  "source": "ndc",
  "strength": "500",
  "substance": "METHYLPREDNISOLONE SODIUM SUCCINATE",
  "productndc": "51662-1483",
  "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/4mL",
  "application_number": "NDA011856",
  "marketing_category": "NDA"
}

See everything about methylprednisolone sodium succinate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.